Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Health Care Costs
1,521 - 1,540 of 1,848 Results
-
-
They May Owe Nothing — Half-Million-Dollar Dialysis Bill Canceled
After reporting by KHN, NPR and CBS, Fresenius has agreed to waive a Montana man’s huge bill for out-of-network dialysis care.
By Jenny Gold -
Klobuchar Says D.C. Has Enough Drug Lobbyists To Double-Team Lawmakers
The drug industry has the biggest lobbying war chest.
-
GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
-
KHN’s ‘What The Health?’: Cue The Drug Price Debate
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.
-
Watch: Out-Of-Network Outrage After A $540K Charge For Dialysis
CBS This Morning covers the highest KHN-NPR Bill of the Month yet: more than half a million dollars for just 14 weeks of kidney dialysis in Montana.
-
Your Go-To Guide To Decode Medical Bills
Kaiser Health News gives you a user-friendly toolkit to help patients understand some of the ins and outs of medical billing, what to do if you receive a surprise medical bill and things to keep in mind before getting medical care.
-
First Kidney Failure, Then A $540,842 Bill For Dialysis
He needed the lifesaving treatment — he never expected a half-million-dollar bill for 14 weeks of care.
By Jenny Gold -
On A Mission To Help People Control Diabetes — And Save Money On Insulin
Patients with Type 2 diabetes are often steered toward medicine or insulin treatment. But with additional support, it’s possible to use diet and exercise to control blood sugar. The rising price of insulin drives patients to lower their dependence on the medicine.
-
‘An Arm And A Leg’: Real Lessons Doctors Can Learn From Fake Patients
Are physicians asking patients the right questions in order to provide good care? Laser-focused on biomedical symptoms, some doctors miss the psychosocial factors that can be a barrier to good health. In Episode 7 of the podcast, we hear about a creative study that uncovers how some medical errors happen.
-
Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
-
Why It’s So Hard To Predict How Much Funding 9/11 First Responders Need
Eighteen years ago, most first responders were not thinking about their future health when they spent hours searching “The Pile” for the remains of terror victims. Today, their illnesses are a slow-moving epidemiological nightmare that has been as difficult for scientists to study as it has been easy for politicians to overlook.
-
Federal Suit Alleges ‘Staggering’ Urine Drug Testing Fraud At Tennessee Pain Clinics
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
By Fred Schulte -
Dream Of Retiring Abroad? The Reality: Medicare Doesn’t Travel Well
More than 400,000 U.S. workers have retired in foreign countries and their ranks are rising. But Medicare doesn’t cover most expenses overseas, so these expats will need to confront the cost of finding alternative insurance.
-
Biden’s ‘Incremental’ Health Plan Still Would Be A Heavy Lift
The proposal is far from minimal and includes several provisions that Congress has failed repeatedly to enact, including some that were part of the original Affordable Care Act debate.
By Julie Rovner -
A Conservative Group Paints Trump’s Drug-Pricing Experiment As ‘Socialist.’ Is It?
The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president’s promise to curb high drug prices.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN’s ‘What The Health?’: Biden Doubles Down On Obamacare
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.
-
KHN Investigation On Opioid Prescribers Pains Some Readers And Tweeters
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Surprise Medical Bill Legislation Takes A Step Forward, But Will It Lead To A Step Back?
A House committee approved its version of legislation to solve the problem of surprise medical bills. But the measure includes a key provision that’s got less support in the Senate.
By Rachel Bluth